ClinicalTrials.gg
CompletedNCT03979469Updated Jul 14, 2020

Opioid Versus Non-opioid Anesthesia for Ambulatory Surgery in Children

A Phase 2 interventional study of Ketamine, dexmedetomidine and fentanyl, remifentanil in Effect of Anesthesia in Postoperative Pain, Effect of Anesthesia in Extubation Time and Effect of Anesthesia in Discharge Time From Postanesthesia Care Unit, sponsored by Athens General Children's Hospital "Pan. & Aglaia Kyriakou". Completed at 1 site in Greece. Open to participants aged 3 Years to 16 Years. Per ClinicalTrials.gov, last updated 2020-07-14.

Sponsored by Athens General Children's Hospital "Pan. & Aglaia Kyriakou" · Phase 2, Interventional, and Other

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Aug 2018, registered May 2019).
Phase
Phase 2
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
3 Years to 16 Years
Sex
All
01

Study summary

The investigators intend to study the safety and effectiveness of opioid free anesthesia compared to opioid anesthesia in ambulatory surgery in children, regarding postoperative pain, hemodynamic stability, agitation and discharge times. Quality of postanesthetic care was estimated in a 24h follow up.

02

Conditions studied

  • Effect of Anesthesia in Postoperative Pain
  • Effect of Anesthesia in Extubation Time
  • Effect of Anesthesia in Discharge Time From Postanesthesia Care Unit
  • Effect of Anesthesia in Postoperative Adverse Events
  • Effect of Anesthesia in Discharge Time From the Hospital

Browse trials for

03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's enrollment of 100 is above the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Athens General Children's Hospital "Pan. & Aglaia Kyriakou" is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children,
  • American Society Anesthesia I, II,
  • ambulatory surgery

Exclusion criteria

Exclusion Criteria:

  • Allergy to anesthetic and analgesic drugs,
  • history of neuromuscular,
  • renal, neurological, hepatic disease,
  • craniofacial anomalies,
  • Obstructive Sleep Apnea,
  • obesity,
  • cardiopulmonary diseases
05

Study design

Phase
Phase 2
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    opiod free general anesthesia

    In group A opioid free anesthesia is administered. Anesthesia and analgesia were achieved with ketamine(1mg/kg, bolus), dexmedetomidine(1mcg/kg, over 10 minutes), local anesthetic(ropivacaine 2mg/kg 0.75% wound infiltration), paracetamol(15mg/kg), non steroid analgesics(diclofenac 1mg/kg). Anesthesia induction with ketamine(1mg/kg), propofol 1% 2-3mg/kg, rocuronium 1mg/kg. Anesthesia maintenance with propofol 1% 10mg/kg/hour. Reversal of rocuronium with sugammadex 2mg/kg.

    Drug: Ketamine, dexmedetomidine

  • Active comparator
    opioid based general anesthesia

    In group B opioid based anesthesia is administered.Anesthesia and analgesia were achieved with remifentanil(0.3mcg/kg/minute), local anesthetic(ropivacaine 2mg/kg 0.75% wound infiltration), paracetamol(15mg/kg), non steroid analgesics(diclofenac 1mg/kg).Anesthesia induction with propofol 1% 2-3mg/kg,fentanyl(2mcg/kg), rocuronium 1mg/kg. Anesthesia maintenance with propofol 1% 10mg/kg/hour. Reversal of rocuronium with sugammadex 2mg/kg.

    Drug: fentanyl, remifentanil

Interventions

  • DrugKetamine, dexmedetomidine

    Drug pages: Ketamine · Dexmedetomidine

    Patients will receive non-opioid analgesics, such as dexmedetomidine, ketamine perioperatively

  • Drugfentanyl, remifentanil

    Drug pages: Fentanyl · Remifentanil

    Patients will receive opioid analgesics, such as fentanyl and remifentanil perioperatively

06

What researchers measure

Primary outcomes

  1. Discharge times from the hospital

    Comparison of the discharge times from the hospital between opioid free and opioid based anesthesia using Discharge criteria based on physiological scoring system, evaluating respiration, circulation, level of consciousness, postoperative pain, postoperative nausea and vomiting and surgical site. A score 12 or more allows patient to leave safely from the hospital.

    Time frame: 4 hours

  2. Severity of postoperative pain

    Comparison of the severity of postoperative pain between opioid free and opioid based anesthesia using Visual Analogue Scale for children aged 7 years and more. We instruct the patient to point to the position on the line between the faces to indicate how much pain they are currently feeling. The far left end indicates "no pain"(0) and the far right end indicates "worst pain ever."(10)

    Time frame: 24 hours

  3. Severity of postoperative pain

    Comparison of the severity of postoperative pain between opioid free and opioid based anesthesia using the Face, Legs, Activity, Cry, Consolability scale or FLACC scale for children between the ages of 3 years and 7 years. The scale has five criteria, which are each assigned a score of 0, 1 or 2.The scale is scored in a range of 0-10 with 0 representing no pain.

    Time frame: 24 hours

Secondary outcomes

  1. Extubation time

    Comparison of extubation time, time interval between discontinuation of anesthetics and extubation between the two groups

    Time frame: 30 minutes

  2. Discharge time from PACU

    Comparison of discharge time from postanesthesia unit, time interval between arrival from operating room until leaving postanesthesia unit, between the two groups using Aldrete scale, score of 9 or greater allows patient to leave postanesthesia unit

    Time frame: 60 minutes

  3. Cost effect

    Comparison of hospitalization fees among the two groups

    Time frame: 24 hours

07

Study locations

1 site
  • Childrens Hospital P. and A. Kyriakou Anesthesiology Department
    Athens, 11526, Greece
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 14, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03979469
Lead sponsor
Athens General Children's Hospital "Pan. & Aglaia Kyriakou"
Responsible party
Adelais Tsiotou (Consultant of Anesthesiology Department, Athens General Children's Hospital "Pan. & Aglaia Kyriakou") — Principal investigator
First posted
Jun 7, 2019
Start date
Aug 1, 2018
Primary completion
Aug 1, 2019
Completion
Aug 1, 2019
Last update
Jul 14, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Ketamine · Dexmedetomidine

Start the discussion